PLx Pharma Winddown Corp. Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
PLx Pharma Winddown Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q3 2022.
  • PLx Pharma Winddown Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
  • PLx Pharma Winddown Corp. Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $0.000.
  • PLx Pharma Winddown Corp. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • PLx Pharma Winddown Corp. annual Income Tax Expense (Benefit) for 2020 was $0.000.
  • PLx Pharma Winddown Corp. annual Income Tax Expense (Benefit) for 2017 was -$920K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q2 2017 -$920K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2015 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-13
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.